Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
8th grade Avg
|
New words:
abandon, absolute, accident, Accrual, acuity, added, aforementioned, alerting, alpha, AMD, API, appetite, ARB, beneficiary, bleeding, blockage, broader, brought, capsule, central, cGMP, circumvented, classify, code, codified, comfort, complaint, complex, complication, conceived, conference, consolidated, consolidation, costly, Counteracting, Countering, coverage, decision, deem, deemed, deferral, degeneration, detached, detect, detected, devote, difficult, discharge, disrupt, disruption, District, DME, dr, drawn, driver, dysregulation, eased, element, eliminate, elimination, embody, encounter, endpoint, exempt, extremely, eye, Eyetech, factual, fall, FAQ, farther, faster, feature, FIN, fine, flexibility, fluid, formula, found, freestanding, fused, fusion, guarantor, headcount, heading, healthcare, heavily, hire, history, hormonal, hurt, hypersensitivity, hypertension, IIb, immunoglobulin, immunological, impede, improper, improperly, inadequate, increasingly, infrastructure, infusion, inherent, inhibitor, instrument, interpretation, intravenously, intravitreal, invalidated, issuer, lab, landlord, lawsuit, leakage, lesser, Letter, liable, LIBOR, literature, Macugen, macula, macular, magnitude, mandatorily, marketplace, mechanism, merit, metabolic, metabolism, modulate, mutation, neovascular, neural, neuropeptide, noncontrolling, nutritional, older, oncology, ophthalmology, oppose, opposed, ordinarily, overhead, partly, pathogenic, peripheral, permission, Placental, PLGF, pocket, preexisting, proceed, proliferation, promoting, promulgated, proteinuria, purport, Qualitative, Quantitative, RA, radioactive, recruit, reduction, reevaluate, refine, refusal, relevance, replenishment, rescind, rescission, residual, resolution, retina, retinal, revision, sensitive, shortened, shortly, slightly, Southern, staggered, STATEMENTSFor, Substantive, succeed, suitable, superceded, surgical, tablet, threshold, tied, tightly, Topic, transaction, unauthorized, unchanged, unclear, uncompetitive, undertaken, unfavorable, Union, unregistered, unspecified, unsuccessful, vial, view, violation, visual, voluntary, waste, wet, wording
Removed:
alarming, allocated, allocation, amendment, antigen, appointed, asserting, assuming, bearing, billable, binding, breach, breakthrough, catching, cautionary, chance, characterization, characterizing, China, civil, collateralized, commence, compensated, composed, constipating, contracted, contracting, cough, criminal, daily, declaration, deficit, Delaware, determinable, diseased, distribute, dosing, dual, enrollment, Ernst, expended, exploitation, external, feasibility, formed, frequent, Glaxo, inactivated, individual, inform, initiating, intended, invested, irregular, Japanese, kg, kilogram, knockin, land, leak, level, locate, lost, mcg, measurable, memorandum, mimic, mortgage, mouse, nausea, noncompetitive, notable, obese, offered, opportunity, opt, orally, organizational, overact, pegaxokine, pharmacokinetic, plc, proof, propose, pursued, randomized, readily, reflected, rendered, renovation, replaced, requested, retaining, review, Security, served, shearwater, simplex, site, situation, solicitation, staffing, steering, structural, subsidiary, Takeda, territory, threat, trapped, treating, turn, underlying, unmodified, unusual, validation, validity, vomiting, Wellcome, withdrawal, withholding, writing, wrong, Young
Filing tables
Filing exhibits
REGN similar filings
Filing view
External links
Exhibit 23.1
CONSENT OF INDEPENDENT ACCOUNTANTS
We hereby consent to the incorporation by reference in the Registration Statements on Form S-8 (File Nos. 33-50480, 33-85330, 33-97176, 333-33891, 333-80663, 333-61132, and 333-97375) and on Form S-3 (File No. 333-74464) of Regeneron Pharmaceuticals, Inc., of our report, which is based in part on the report of other auditors, dated January 30, 2004, except for the last paragraph of Note 11b, as to which the date is February 27, 2004, relating to the financial statements which appear in this Annual Report on Form 10-K.
PricewaterhouseCoopers LLP |
New York, New York
March 10, 2004